Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_assertion type Assertion NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_head.
- NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_assertion description "[Systemic LDL oxidation and monocyte chemoattractant protein 1 and the expression of proatherogenic genes in peripheral blood mononuclear cells [ie, CD40 ligand (CD40L), IL-23? subunit p19 (IL23A), adrenergic ?-2 receptor (ADRB2), oxidized LDL (lectin-like) receptor 1 (OLR1), and IL-8 receptor-? (IL8RA)] decreased after the HPC intervention compared with after the LPC intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_provenance.
- NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_assertion evidence source_evidence_literature NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_provenance.
- NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_assertion SIO_000772 22440854 NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_provenance.
- NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_assertion wasDerivedFrom befree-2016 NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_provenance.
- NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_assertion wasGeneratedBy ECO_0000203 NP969742.RA--OZR6fCmF3zis5_RObLMuBPNCq6l798-0K1_z2phjc130_provenance.